Market Overview

Bio-Rad Acquires Cell Sorting System From Propel Labs

Share:
Related BIO
5 Health Care Stocks Hurting From The Affordable Care Act
UPDATE: Bio-Rad Labs Announces Resolution of Foreign Corrupt Practices Act

Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products today announced that they have acquired a new cell sorting system from Propel Labs. Under the terms of agreement, Bio-Rad has acquired an automated, easy-to-use benchtop sorting flow cytometer. The instrument will be offered by Bio-Rad as the S3(TM) Cell Sorter. First shipments are anticipated in January 2013. Other terms of the agreement were not disclosed.

Posted-In: News Asset Sales

 

Related Articles (BIO)

View Comments and Join the Discussion!